Do Decreased CEP17 Signals Indicate the Presence of "Monosomy" in Breast Cancer? A Study of HER2 Gene Status and HER2 Immunohistochemistry.

被引:0
|
作者
Tse, C. H. [1 ]
Hwang, H. C. [1 ]
Goldstein, L. C. [1 ]
Kandalaft, P. L. [1 ]
Duesterhoeft, S. M. [1 ]
Kussick, S. L. [1 ]
Gown, A. M. [1 ]
机构
[1] PhenoPath Labs, Seattle, WA USA
关键词
D O I
10.1158/0008-5472.SABCS11-P4-09-04
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-09-04
引用
收藏
页数:2
相关论文
共 50 条
  • [31] HER2 in-Situ hybridization positive breast cancers with HER2/CEP17 ratio ≥2.0 and average HER2 copy number <4.0 are frequently discordant with HER2 immunohistochemistry results: Implications for potential modification of testing algorithm
    Livasy, Chad
    Johnson, Nicole
    Domfeh, Akosua
    CANCER RESEARCH, 2018, 78 (04)
  • [32] Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations
    Lambein, Kathleen
    Praet, Marleen
    Forsyth, Ramses
    Van den Broecke, Rudy
    Braems, Geert
    Matthys, Bart
    Cocquyt, Veronique
    Denys, Hannelore
    Pauwels, Patrick
    Libbrecht, Louis
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (03) : 200 - 207
  • [33] The prognostic importance of high HER2 copy numbers and high HER2/CEP17 ratio in trastuzumab-treated early breast cancer
    Ronnlund, C.
    Robertson, S.
    Sifakis, E. G.
    Fredriksson, I.
    Foukakis, T.
    Hartman, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S614 - S614
  • [34] Pathologic Features and Clinical Outcomes of HER2 FISH Cases with HER2:CEP17 ratio &gt; 2.0 but &lt; 4 HER2 signals/cell; A Multi-Institutional Study
    Ballard, Morgan
    Toukatly, Mirna
    Bean, Gregory
    Jalikis, Florencia
    Krings, Gregor
    Schmidt, Rodney
    Chen, Yunn-Yi
    Dintzis, Suzanne
    Troxell, Megan
    West, Robert
    Sibley, Richard
    Allison, Kimberly
    LABORATORY INVESTIGATION, 2018, 98 : 47 - 48
  • [35] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [36] Pathologic Features and Clinical Outcomes of HER2 FISH Cases with HER2: CEP17 ratio &gt; 2.0 but &lt; 4 HER2 signals/cell; A Multi-Institutional Study
    Ballard, Morgan
    Toukatly, Mirna
    Bean, Gregory
    Jalikis, Florencia
    Krings, Gregor
    Schmidt, Rodney
    Chen, Yunn-Yi
    Dintzis, Suzanne
    Troxell, Megan
    West, Robert
    Sibley, Richard
    Allison, Kimberly
    MODERN PATHOLOGY, 2018, 31 : 47 - 48
  • [37] Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study
    Sekmek, Serhat
    Karahan, Irfan
    Ucar, Gokhan
    Ceylan, Furkan
    Bayram, Dogan
    Seven, Ismet
    Bolek, Hatice
    Urun, Yuksel
    Yucel, Kadriye Bir
    Yazici, Ozan
    Kadioglu, Ahmet
    Karacin, Cengiz
    Canaslan, Kubra
    Atag, Elif
    Demirer, Serhat
    Erdem, Gokmen Umut
    Ergun, Yakup
    Atak, Mehmetcan
    Koksal, Baris
    Kiran, Merve Meryem
    Turkay, Duriye Ozer
    Civelek, Burak
    Yalcin, Bulent
    Uncu, Dogan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08): : 1878 - 1885
  • [38] Discordance between HER2 Copies/Cell and HER2/CEP17 Ratio by Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinoma
    Czapla, A.
    Silverman, J. F.
    Krishnamurti, U.
    MODERN PATHOLOGY, 2014, 27 : 43A - 43A
  • [39] Relationship between survival to breast cancer and level of HER2 expression by immunohistochemistry.
    Provencher, Louise
    Diorio, Caroline
    Desbiens, Christine
    Poirier, Brigitte
    Poirier, Eric
    Boudreau, Dominique
    Doyle, Catherine
    Popa, Ion
    Gagne, Isabelle
    Hogue, Jean-Charles
    Lemieux, Julie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Discordance between HER2 Copies/Cell and HER2/CEP17 Ratio by Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinoma
    Czapla, A.
    Silverman, J. F.
    Krishnamurti, U.
    LABORATORY INVESTIGATION, 2014, 94 : 43A - 43A